Did you ever hear of bonus pills when buying Biaxin at your local pharmacy?

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c41513) has announced the addition of the new report from Espicom Business Intelligence Ltd. “Abbott Laboratories Prospects to 2010″ to their offering.
Pharmac…

Resistance to antibiotics by pathogens is an increasingly serious problem worldwide. By 1999, approximately 25 percent of isolates from invasive infections caused by Streptococcus pneumoniae in the United States and many other countries were resistant to macrolides. This rapid increase followed the introduction of the new macrolides azithromycin (Zithromax) and clarithromycin (Biaxin). Macrolide resistance was predominantly reported in pneumococcal serotypes 14, 19F, …

The concept esomeprazole refers to the S-isomer of omeprazole contains the mixture of the s-and R- isomers. Talking about esomeprazole magnesium drug description, it has molecular formula and structural formula. The strength of esomeprazole magnesium is a function of pH; which quickly degrades in acidic media. However, under alkaline state it has acceptable solidity.

There are some side effects of using esomeprazole magnesium like according to clinical res…

TO THE EDITOR: We read with great interest the review on Helicobacter pylori in American Family Physician. (1) However, some of the authors’ suggestions on the treatment of this condition could be misleading to readers.
The authors reported that a standard tri…

Business Editors
ROSWELL, Ga.–(BUSINESS WIRE)–March 1, 2000
First Horizon Pharmaceutical(TM)Corporation, an emerging pharmaceutical company, announced today the appointment of John E. Robson and Jon S. Saxe to the Board of Directors and the appointment of…

* Clinical question
What is the optimum duration of treatment for Helicobacter pylori eradication?
* Bottom line
Seven days of treatment with triple therapy–a proton pump inhibitor (PPI) plus clarithromycin (Biaxin) plus amoxicillin or metronidazole–produces rat…

CHICAGO — Fitch has assigned an ‘AA-’ rating to Abbott Laboratories’ (Abbott) proposed public issuance of $4 billion of senior notes. The notes will be offered in three tranches with three-year, five-year, and 10-year terms. The Rating Outlook is Stable.
Abbott’s ratings are:
— Issuer Default Rating (IDR) ‘AA-’;
— Bank loan debt ‘AA-’;
— Senior unsecured debt ‘AA-’;
— Co…

FORT LAUDERDALE, Fla. — Andrx Corporation (Nasdaq: ADRX) (”Andrx” or “Company”) announced today that the U.S. District Court for the District of Northern Illinois granted Abbott Laboratories’ motion for a preliminary injunction related to Andrx’s generic Clarithromycin Extended Release Tablets pending a trial on the merits. The Company is evaluating the …

CHICAGO — Fitch Ratings does not expect the ratings and Outlook for Abbott Laboratories (Abbott) to change in light of the company’s announcement of its intention to acquire Guidant’s (Guidant Corporation) vascular business for approximately $3.8 bi…

For many years now,sinus infection antibiotics have been used to treat bacterial sinus infections without disappointing anyone. However,different antibiotics are usually used to treat different types of sinus bacterial infections that a person may …